Epigenetic modulation of the HeLa cell membrane N-glycome

Biochimica et Biophysica Acta - General Subjects

Volumn 1820, Issue 9, 2012, Pages 1412-1419

  Horvat, Tomislav ^a   Mužinić, Ana ^b   Barišić, Darko ^a   Bosnar, Maja Herak ^c   Zoldoš, Vlatka ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b GENOS GLYCOSCIENCE RESEARCH LABORATORY   (Croatia)

^c RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

DNA methylation; Epigenetic inhibitor; HeLa cell line; Histone acetylation; Membrane N glycome; N glycosylation

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BUTYRIC ACID; GLYCAN; TRICHOSTATIN A; ZEBULARINE;

ARTICLE; CARBOHYDRATE ANALYSIS; CARBOHYDRATE TRANSPORT; CELL MEMBRANE PERMEABILITY; CHEMICAL COMPOSITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEACETYLATION; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION REGULATION; GENE TARGETING; GLYCOBIOLOGY; GLYCOSYLATION; HELA CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HYDROPHILIC INTERACTION CHROMATOGRAPHY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; UPREGULATION;

ANTINEOPLASTIC AGENTS; AZACITIDINE; BUTYRATES; CARBOHYDRATE SEQUENCE; CYTIDINE; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOMICS; HELA CELLS; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; MOLECULAR SEQUENCE DATA; POLYSACCHARIDES;

EID: 84862878445     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2011.12.007     Document Type: Article

References (69)

1. R. Apweiler, H. Hermjakob, N. Sharon, On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database, Biochim. Biophys. Acta 1473 (1999) 4-8.
2. G.W. Hart, M.P. Housley, C. Slawson, Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins, Nature 446 (2007) 1017-1022. (Pubitemid 46676063)
3. L. Wells, K. Vosseller, G.W. Hart, Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc, Science 291 (2001) 2376-2378. (Pubitemid 32231793)
4. K.W. Marek, I.K. Vijay, J.D. Marth, A recessive deletion in the GlcNAc-1-phosphotransferase gene results in peri-implantation embryonic lethality, Glycobiology 9 (1999) 1263-1271.
5. A. Knezevic, O. Polasek, O. Gornik, I. Rudan, H. Campbell, C. Hayward, A. Wright, I. Kolcic, N. O'Donoghue, J. Bones, P.M. Rudd, G. Lauc, Variability, heritability and environmental determinants of human plasma N-glycome, J. Proteome Res. 8 (2009) 694-701.
6. M. Pucic, A. Knezevic, J. Vidic, B. Adamczyk, M. Novokmet, O. Polasek, O. Gornik, S. Supraha-Goreta, M.R. Wormald, I. Redzic, H. Campbell, A. Wright, N.D. Hastie, J.F. Wilson, I. Rudan, M. Wuhrer, P.M. Rudd, D. Josic, G. Lauc, High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations, Mol. Cell. Proteomics 10 M111 010090 (2011).
7. S. Takamatsu, A. Antonopoulos, K. Ohtsubo, D. Ditto, Y. Chiba, D.T. Le, H.R. Morris, S.M. Haslam, A. Dell, J.D. Marth, N. Taniguchi, Physiological and glycomic characterization of N-acetylglucosaminyltransferase-IVa and -IVb double deficient mice, Glycobiology 20 (2010) 485-497.
8. D. Skropeta, The effect of individual N-glycans on enzyme activity, Bioorg. Med. Chem. 17 (2009) 2645-2653.
9. J.W. Dennis, I.R. Nabi, M. Demetriou, Metabolism, cell surface organization, and disease, Cell 139 (2009) 1229-1241.
10. J.W. Dennis, K.S. Lau, M. Demetriou, I.R. Nabi, Adaptive regulation at the cell surface by N-glycosylation, Traffic 10 (2009) 1569-1578.
11. F. Yan, D.B. Polk, Commensal bacteria in the gut: learning who our friends are, Curr. Opin. Gastroenterol. 20 (2004) 565-571. (Pubitemid 39447166)
12. D. Artis, Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut, Nat. Rev. Immunol. 8 (2008) 411-420. (Pubitemid 351733416)
13. D. Kelly, S. Conway, R. Aminov, Commensal gut bacteria: mechanisms of immune modulation, Trends Immunol. 26 (2005) 326-333. (Pubitemid 40732666)
14. L.V. Hooper, Bacterial contributions to mammalian gut development, Trends Microbiol. 12 (2004) 129-134. (Pubitemid 38314756)
15. G. Felsenfeld, M. Groudine, Controlling the double helix, Nature 421 (2003) 448-453. (Pubitemid 36157954)
16. X. Nan, H.H. Ng, C.A. Johnson, C.D. Laherty, B.M. Turner, R.N. Eisenman, A. Bird, Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex, Nature 393 (1998) 386-389. (Pubitemid 28269714)
17. A. Bird,DNAmethylation patterns and epigeneticmemory,GenesDev. 16 (2002) 6-21.
18. J.E. Ohm, K.M. McGarvey, X. Yu, L. Cheng, K.E. Schuebel, L. Cope, H.P. Mohammad,W. Chen,V.C.Daniel,W. Yu, D.M. Berman, T. Jenuwein, K. Pruitt, S.J. Sharkis, D.N.Watkins, J.G. Herman, S.B. Baylin, A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing, Nat. Genet. 39 (2007) 237-242.
19. M. Widschwendter, H. Fiegl, D. Egle, E. Mueller-Holzner, G. Spizzo, C. Marth, D.J. Weisenberger, M. Campan, J. Young, I. Jacobs, P.W. Laird, Epigenetic stem cell signature in cancer, Nat. Genet. 39 (2007) 157-158. (Pubitemid 46184343)
20. J.F. Costello, C. Plass, Methylation matters, J. Med. Genet. 38 (2001) 285-303. (Pubitemid 32433981)
21. P.A. Jones, S.B. Baylin, The fundamental role of epigenetic events in cancer, Nat. Rev. Genet. 3 (2002) 415-428. (Pubitemid 34587077)
22. V. Zoldoš, S. Grgurević, G. Lauc, Epigenetic regulation of protein glycosylation, Biomol. Concepts 1 (2010) 253-261.
23. T. Horvat, V. Zoldoš, G. Lauc, Evolutional and clinical implications of the epigenetic regulation of protein glycosylation, Clin. Epigenetics 2 (2011) 425-432.
24. M.M. Fuster, J.D. Esko, The sweet and sour of cancer: glycans as novel therapeutic targets, Nat. Rev. Cancer 5 (2005) 526-542. (Pubitemid 40942829)
25. P.M. Drake, W. Cho, B. Li, A. Prakobphol, E. Johansen, N.L. Anderson, F.E. Regnier, B.W. Gibson, S.J. Fisher, Sweetening the pot: adding glycosylation to the biomarker discovery equation, Clin. Chem. 56 (2010) 223-236.
26. C.B. Yoo, J.C. Cheng, P.A. Jones, Zebularine: a newdrug for epigenetic therapy, Biochem. Soc. Trans. 32 (2004) 910-912.
27. P. Marks, R.A. Rifkind, V.M. Richon, R. Breslow, T.Miller,W.K. Kelly, Histone deacetylases and cancer: causes and therapies, Nat. Rev. Cancer 1 (2001) 194-202. (Pubitemid 33741894)
28. Y.I. Kawamura,M. Toyota, R. Kawashima, T. Hagiwara, H. Suzuki, K. Imai, Y. Shinomura, T. Tokino, R. Kannagi, T. Dohi, DNA hypermethylation contributes to incomplete synthesis of carbohydrate determinants in gastrointestinal cancer, Gastroenterology 135 (2008) 142-151 e143.
29. Y.S. Kim, G. Deng, Aberrant expression of carbohydrate antigens in cancer: the role of genetic and epigenetic regulation, Gastroenterology 135 (2008) 305-309. (Pubitemid 351899050)
30. L. Royle, M.P. Campbell, C.M. Radcliffe, D.M. White, D.J. Harvey, J.L. Abrahams, Y.G. Kim, G.W. Henry, N.A. Shadick, M.E. Weinblatt, D.M. Lee, P.M. Rudd, R.A. Dwek, HPLC-based analysis of serumN-glycans on a 96-well plate platformwith dedicated database software, Anal. Biochem. 376 (2008) 1-12.
31. S.M. Taylor, P.A. Jones, Mechanism of action of eukaryotic DNA methyltransferase. Use of 5-azacytosine-containing DNA, J. Mol. Biol. 162 (1982) 679-692. (Pubitemid 13113000)
32. J.C. Cheng, C.B. Matsen, F.A. Gonzales, W. Ye, S. Greer, V.E. Marquez, P.A. Jones, E.U. Selker, Inhibition of DNA methylation and reactivation of silenced genes by zebularine, J. Natl. Cancer Inst. 95 (2003) 399-409. (Pubitemid 36395260)
33. P. Chiurazzi,M.G. Pomponi, R. Pietrobono, C.E. Bakker, G. Neri, B.A. Oostra, Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene, Hum. Mol. Genet. 8 (1999) 2317-2323. (Pubitemid 29525348)
34. E.U. Selker, Trichostatin A causes selective loss of DNA methylation in Neurospora, Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 9430-9435. (Pubitemid 28506248)
35. Y. Jitsuhara, T. Toyoda, T. Itai, H. Yamaguchi, Chaperone-like functions of high-mannose type and complex-type N-glycans and their molecular basis, J. Biochem. 132 (2002) 803-811. (Pubitemid 35408505)
36. M.L. de Leoz, L.J. Young, H.J. An, S.R. Kronewitter, J. Kim, S. Miyamoto, A.D. Borowsky, H.K. Chew, C.B. Lebrilla, High-mannose glycans are elevated during breast cancer progression, Mol. Cell. Proteomics 10 M110 002717 (2011).
37. A. Hassinen, F.M. Pujol, N. Kokkonen, C. Pieters, M. Kihlstrom, K. Korhonen, S. Kellokumpu, Functional organization of Golgi and O-glycosylation pathways involves pH-dependent complex formation that is impaired in cancer cells, J. Biol. Chem. 286 (2011) 38329-38340.
38. G. Liang, F.A. Gonzales, P.A. Jones, T.F. Orntoft, T. Thykjaer, Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-aza-2′-deoxycytidine, Cancer Res. 62 (2002) 961-966. (Pubitemid 34160269)
39. J.C. Cheng, C.B. Yoo, D.J.Weisenberger, J. Chuang, C.Wozniak, G. Liang, V.E.Marquez, S. Greer, T.F. Orntoft, T. Thykjaer, P.A. Jones, Preferential response of cancer cells to zebularine, Cancer Cell 6 (2004) 151-158. (Pubitemid 39485687)
40. D.V. Santi, A.Norment, C.E. Garrett, Covalent bond formation between a DNA-cytosine methyltransferase and DNA containing 5-azacytosine, Proc. Natl. Acad. Sci. U. S. A. 81 (1984) 6993-6997. (Pubitemid 15216684)
41. L. Zhou, X. Cheng, B.A. Connolly, M.J. Dickman, P.J. Hurd, D.P. Hornby, Zebularine: a novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases, J. Mol. Biol. 321 (2002) 591-599. (Pubitemid 36124798)
42. J. Bouchard, R.L. Momparler, Incorporation of 5-Aza-2′- deoxycytidine-5′- triphosphate into DNA. Interactions with mammalian DNA polymerase alpha and DNA methylase, Mol. Pharmacol. 24 (1983) 109-114. (Pubitemid 13075113)
43. M. Reichman, S. Penman, The mechanism of inhibition of protein synthesis by 5- azacytidine in HeLa cells, Biochim. Biophys. Acta 324 (1973) 282-289.
44. T. Ben-Kasus, Z. Ben-Zvi, V.E. Marquez, J.A. Kelley, R. Agbaria, Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells, Biochem. Pharmacol. 70 (2005) 121-133. (Pubitemid 40797876)
45. N. Taniguchi, E. Miyoshi, J.H. Ko, Y. Ikeda, Y. Ihara, Implication of N-acetylglucosaminyltransferases III and V in cancer: gene regulation and signaling mechanism, Biochim. Biophys. Acta 1455 (1999) 287-300. (Pubitemid 29435995)
46. G. Lauc, A. Essafi, J.E. Huffman, C. Hayward, A. Knezevic, J.J.Kattla,O.Polasek,O.Gornik, V. Vitart, J.L. Abrahams, M. Pucic, M. Novokmet, I. Redzic, S. Campbell, S.H.Wild, F. Borovecki, W. Wang, I. Kolcic, L. Zgaga, U. Gyllensten, J.F. Wilson, A.F. Wright, N.D. Hastie, H. Campbell, P.M. Rudd, I. Rudan, Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1alpha as a master regulator of plasma protein fucosylation, PLoS Genet. 6 (2010) e1001256.
47. M.N. Ndlovu, H. Denis, F. Fuks, Exposing the DNA methylome iceberg, Trends (2010) Biochem. Sci. 36 (2011) 381-387.
48. H. Denis, M.N. Ndlovu, F. Fuks, Regulation of mammalian DNA methyltransferases: a route to new mechanisms, EMBO Rep. 12 (2011) 647-656.
49. L. Laurent, E. Wong, G. Li, T. Huynh, A. Tsirigos, C.T. Ong, H.M. Low, K.W. Kin Sung, I. Rigoutsos, J. Loring, C.L. Wei, Dynamic changes in the human methylome during differentiation, Genome Res. 20 (2010) 320-331.
50. E. Vire, C. Brenner, R. Deplus, L. Blanchon, M. Fraga, C. Didelot, L. Morey, A. Van Eynde, D. Bernard, J.M. Vanderwinden, M. Bollen, M. Esteller, L. Di Croce, Y. de Launoit, F. Fuks, The Polycomb group protein EZH2 directly controlsDNAmethylation, Nature 439 (2006) 871-874. (Pubitemid 43255707)
51. Y. Schlesinger, R. Straussman, I. Keshet, S. Farkash, M. Hecht, J. Zimmerman, E. Eden, Z. Yakhini, E. Ben-Shushan, B.E. Reubinoff, Y. Bergman, I. Simon, H. Cedar, Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer, Nat. Genet. 39 (2007) 232-236. (Pubitemid 46184355)
52. K.M. Schmitz, C. Mayer, A. Postepska, I. Grummt, Interaction of noncoding RNA with the rDNA promoter mediates recruitment of DNMT3b and silencing of rRNA genes, Genes Dev. 24 (2010) 2264-2269.
53. V.M. Richon, T.W. Sandhoff, R.A. Rifkind, P.A. Marks, Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation, Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 10014-10019.
54. C. Van Lint, S. Emiliani, E. Verdin, The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation, Gene Expr. 5 (1996) 245-253.
55. J. Landry, A. Sutton, S.T. Tafrov, R.C. Heller, J. Stebbins, L. Pillus, R. Sternglanz, The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases, Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 5807-5811. (Pubitemid 30367480)
56. M. Yoshida, M. Kijima, M. Akita, T. Beppu, Potent and specific inhibition ofmammalian histone deacetylase both in vivo and in vitro by trichostatin A, J. Biol. Chem. 265 (1990) 17174-17179.
57. R.L. Cai, Y. Yan-Neale, M.A. Cueto, H. Xu, D. Cohen, HDAC1, a histone deacetylase, forms a complex with Hus1 and Rad9, two G2/M checkpoint Rad proteins, J. Biol. Chem. 275 (2000) 27909-27916.
58. V. Sharma, N. Koul, C. Joseph, D. Dixit, S. Ghosh, E. Sen, HDAC inhibitor, scriptaid, induces glioma cell apoptosis through JNK activation and inhibits telomerase activity, J. Cell. Mol. Med. 14 (2010) 2151-2161.
59. S.Y. Roth, J.M. Denu, C.D. Allis, Histone acetyltransferases, Annu. Rev. Biochem. 70 (2001) 81-120. (Pubitemid 32662206)
60. S. Khochbin, A. Verdel, C. Lemercier, D. Seigneurin-Berny, Functional significance of histone deacetylase diversity, Curr. Opin. Genet. Dev. 11 (2001) 162-166. (Pubitemid 32209200)
61. H. Schachter, Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides, Biochem. Cell Biol. 64 (1986) 163-181. (Pubitemid 16036405)
62. V.M. Richon, S. Emiliani, E. Verdin, Y. Webb, R. Breslow, R.A. Rifkind, P.A. Marks, A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases, Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 3003-3007. (Pubitemid 28135844)
63. K.S. Lau, E.A. Partridge, A. Grigorian, C.I. Silvescu, V.N. Reinhold, M. Demetriou, J.W. Dennis, Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation, Cell 129 (2007) 123-134. (Pubitemid 46507588)
64. I.O. Potapenko, V.D. Haakensen, T. Luders, A. Helland, I. Bukholm, T. Sorlie, V.N. Kristensen, O.C. Lingjaerde, A.L. Borresen-Dale, Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression, Mol. Oncol. 4 (2010) 98-118.
65. C.A. Reis, H. Osorio, L. Silva, C. Gomes, L. David, Alterations in glycosylation as biomarkers for cancer detection, J. Clin. Pathol. 63 (2010) 322-329.
66. A. Varki, R. Kannagi, B.P. Toole, Glycosylation change in cancer, in: A. Varki, R.D. Cummings, J.D. Esko, et al., (Eds.), Essentials of Glycobiology, 2nd edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor (NY), 2009.
67. J.W. Dennis, J. Pawling, P. Cheung, E. Partridge, M. Demetriou, UDP-N-acetylglucosamine: alpha-6-D-mannoside beta1,6 N- acetylglucosaminyltransferase V (Mgat5) deficient mice, Biochim. Biophys. Acta 1573 (2002) 414-422. (Pubitemid 35335452)
68. Y.S. Kim, S.Y. Hwang, H.Y. Kang, H. Sohn, S. Oh, J.Y. Kim, J.S. Yoo, Y.H. Kim, C.H. Kim, J.H. Jeon, J.M. Lee, H.A. Kang, E. Miyoshi, N. Taniguchi, H.S. Yoo, J.H. Ko, Functional proteomics study reveals that N- Acetylglucosaminyltransferase V reinforces the invasive/metastatic potential of colon cancer through aberrant glycosylation on tissue inhibitor of metalloproteinase-1, Mol. Cell. Proteomics 7 (2008) 1-14. (Pubitemid 351248231)
69. J.H. Ko, E. Miyoshi, K. Noda, A. Ekuni, R. Kang, Y. Ikeda, N. Taniguchi, Regulation of the GnT-V promoter by transcription factor Ets-1 in various cancer cell lines, J. Biol. Chem. 274 (1999) 22941-22948.